Sunesis to Present at Upcoming Investor Conferences
February 28 2014 - 8:18AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Daniel Swisher, Chief Executive Officer and President of Sunesis,
will present at two upcoming investor conferences;
- Cowen & Company 34th Annual Health Care Conference Tuesday,
March 4th at 10:40 AM Eastern Time The Boston Marriott Copley
Place, Boston
- 26th Annual Roth Conference Tuesday, March 11th at 10:00 AM
Pacific Time The Ritz Carlton, Dana Point, CA
A live webcast of the presentations will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the
webcast will be archived on the "Calendar of Events" page in the
Investors and Media section of the Sunesis website for two
weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, vosaroxin, in multiple
indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit
http://www.sunesis.com.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Eliza Schleifstein
Argot Partners
917-763-8106
eliza@argotpartners.com
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024